HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fulminant course of angiosarcoma of the scalp on multimodal therapy with paclitaxel, bevacizumab, and radiation.

AuthorsSusanne Darr-Foit, Steven Goetze, Peter Elsner
JournalJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (J Dtsch Dermatol Ges) Vol. 15 Issue 4 Pg. 446-448 (Apr 2017) ISSN: 1610-0387 [Electronic] Germany
PMID28294546 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Bevacizumab
  • Paclitaxel
Topics
  • Antineoplastic Agents, Phytogenic (therapeutic use)
  • Bevacizumab (therapeutic use)
  • Combined Modality Therapy
  • Facial Neoplasms (drug therapy, radiotherapy)
  • Hemangiosarcoma (drug therapy, radiotherapy)
  • Humans
  • Paclitaxel (therapeutic use)
  • Scalp

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: